UBS has revised its price target for Brenntag, lowering it to 80 euros while maintaining a "Buy" rating. The adjustment was made due to a lack of near-term growth acceleration in the industrial and business services sector, resulting in significant changes to the estimates for the chemicals trader.

Despite the revised price target, the shares of Brenntag are still considered undervalued. The analysis, published on October 18, 2024, reflects the ongoing challenges within the market segment. Investors should take into account these adjustments when evaluating their positions in Brenntag.